James M. Daly, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,000 shares at $43.74 ($875K) on 2023-08-14, disclosed to the SEC on 2023-08-15.
Open-market sale of $874k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.71 | 10,000 | $437K | 50.0% |
| 2 | $43.74 | 10,000 | $437K | 50.0% |
| Total | $43.73 avg | 20,000 | $875K | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $15.9M | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |
| HALO | SELL | 2020-08-13 | $2.0M | — | Filing → |